MNKD:NASDAQ
MannKind Corp
$4.13
arrow_downward
-0.72%(-0.030) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MNKD...
Open
$4.15
High
$4.18
Low
$4.08
Mkt. cap
1.33B
Avg. vol.
3.74M
Volume
1.69M
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.24
Beta
1.10
Shares outstanding
321.64M
No. of employees
592
Open
$4.15
High
$4.18
Low
$4.08
Mkt. cap
1.33B
Avg. vol.
3.74M
Volume
1.69M
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.24
Beta
1.10
Shares outstanding
321.64M
No. of employees
592
News stories
From web sources and news partners
Yahoo Finance
·
22 minutes ago
The S&P 500 Has Gone 18 Months Without a 10% Drop. Here's How the Next Year Has Gone After Streaks This Long.
Bloomberg.com
·
3 hours ago
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
The Motley Fool
·
1 hour ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Traders Union
·
1 hour ago
Tom McClellan: NYSE Composite Index better comparison for A-D Line than S&P 500
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
About MannKind Corp
CEOMichael Castagna
Employees592
FoundedFeb 1991
HeadquartersDanbury, Connecticut, United States
SectorHealth Care
IndustryBiotechnology
Websitemannkindcorp.com